Heart valve patients may go home sooner: new study reveals key factors

NCT ID NCT02956915

Completed Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracked 300 patients with severe aortic stenosis who had a minimally invasive heart valve replacement (TAVI) to see how long they stayed in the hospital and why some stayed longer than 3 days. The goal was to find out what factors, like needing a blood transfusion or a pacemaker, lead to longer hospital stays. The results could help doctors plan earlier discharge for suitable patients, saving costs and reducing hospital time for elderly and frail individuals.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE SYMPTOMATIC AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEVERE SYMPTOMATIC AORTIC STENOSIS

Contacts and locations

Show contact details

Locations

AP-HP Bichat - Claude Bernard Hospital

Paris, France
Brest University Hospital

Brest, France
Jacques Cartier Private Hospital

Massy, France
Rennes University Hospital

Rennes, France
Rouen University Hospital

Rouen, France